Get insights into Vir Biotechnology's Q1 2025 earnings call, including ECLIPSE Phase III trial progress, oncology updates, and financial highlights.

Despite a significant revenue drop, Vir Biotechnology Inc (VIR) maintains a strong cash position and progresses in key ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

Influenza viruses are among the most likely triggers of future pandemics. A research team has developed a method that can be used to study the interaction of viruses with host cells in unprecedented ...

The ancestor of the virus that causes COVID-19 left its point of origin in Western China or Northern Laos just several years ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

Humans and animals are not the only ones affected by viruses. Unicellular organisms can also be attacked. In a new study, ...

The COVID-19 virus traveled a similar amount of distance in about the same amount of time as the 2002 SARS virus.

Virologists across the globe are raising alarms over the spread of the H5N1 avian flu virus, which is now infecting not just ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

Researchers from the University of São Paulo in Brazil have discovered that silver nanoparticles produced by a fungus called ...